STOCK TITAN

Biomerica to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Biomerica, Inc. (Nasdaq: BMRA) announced its participation in the upcoming Truist Life Sciences Series and LD Micro Invitational XI investor conferences. CEO Zack Irani will present virtually at the LD Micro event on June 8 at 2:30 PM ET. Additionally, Biomerica will conduct one-on-one investor meetings on June 10 as part of the Truist series. Biomerica focuses on developing advanced diagnostic and therapeutic products, particularly for gastrointestinal and inflammatory diseases, aiming to improve health outcomes and reduce healthcare costs.

Positive
  • None.
Negative
  • None.

IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor conferences: the Truist Life Sciences Series and LD Micro Invitational XI event.

Zack Irani, Chief Executive Officer of Biomerica will be presenting virtually at the LD Micro Invitational XI event on Tuesday, June 8th at 2:30 PM ET. Register to access the LD Micro Invitational XI here.

Biomerica will also be conducting one-on-one investor meetings as part of the Truist Life Science Series on Thursday, June 10th.

About Biomerica (NASDAQ: BMRA)

Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point of care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica’s primarily focus is on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.

Corporate Contact:

John Nesbett /Jennifer Belodeau
IMS Investor Relations
203.972.9200
jnesbett@institutionalms.com 


FAQ

When will Biomerica present at the LD Micro Invitational XI?

Biomerica will present virtually at the LD Micro Invitational XI on June 8, 2021, at 2:30 PM ET.

What investor meetings will Biomerica hold in June 2021?

Biomerica will conduct one-on-one investor meetings on June 10, 2021, as part of the Truist Life Science Series.

Who is presenting for Biomerica at the investor conferences?

Zack Irani, the Chief Executive Officer of Biomerica, will present at the LD Micro Invitational XI.

What is the focus of Biomerica's products?

Biomerica primarily focuses on developing diagnostic and therapeutic products for gastrointestinal and inflammatory diseases.

What is the stock symbol for Biomerica?

The stock symbol for Biomerica is BMRA.

BIOMERICA INC

NASDAQ:BMRA

BMRA Rankings

BMRA Latest News

BMRA Stock Data

4.38M
15.61M
7.22%
12.36%
2.21%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
IRVINE